"Epilepsy Drugs Market is likely to reach nearly USD 5.5 Billion by the year end of 2021.
Market growth can be attributed to factors such as rising incidence of neurological disorders, growing disease awareness, introduction of novel antiepileptic drugs (AEDs), strong government support and initiatives. Moreover, increasing R&D investment and launch of extended-release formulations are further expected to fuel the market growth. However, high cost of patented drugs, concerns over decreasing healthcare costs as part of government austerity measures, particularly in Europe and low accessibility to antiepileptic drugs in low and middle income countries, are likely to restrict the market growth.
Complete report available at http://www.marketreportsonline.com/577631.html
The research report titled “Epilepsy Drugs Market: Global Demand, Growth Potential & Opportunity Outlook 2021” examines the market, competitive landscape and trends of the Global Epilepsy Drug Market. This report analyzes market data and provides a better understanding of Epilepsy Drugs sales value and demand in the Global Market. Market outlook in value terms for the forecasted period for Epilepsy Drugs Market has been detailed in the report. Key trends in terms of collaborations, partnerships and licensing agreements are analysed with details. The report also explores detailed description of growth drivers and inhibitors of the Global Epilpesy Drugs Market.
Company Coverage: UCB,EISAI,Pfizer,Sanofi,Lundbeck.
Purchase a Copy of This Report at http://www.marketreportsonline.com/contacts/purchase.php?name=577631
Key Topics Covered in the Report:
Worldwide Epilepsy Drugs Market Analysis (2013 – 2021)
Worldwide Epilepsy Drugs Market Share (2013 – 2021)
Worldwide Epilepsy Drugs Brand Market Performance (2013 – 2021)
Epilepsy Drugs Market – Major Deal Types
Key Companies Analysis
Key Drivers and Inhibitors of the Epilepsy Drugs Market
Key Epilepsy Drugs Covered in the Report are as follows:
Vimpat (Lacosamide)
Keppra (Levetiracetam)
Briviact (Brivaracetam)
Lamictal (Lamotrigine)
Neurontin (Gabapentin)
Few Points from List of Tables:
Worldwide – Epilepsy Drugs Brand Market Performance (2013 – 2021):
Vimpat(Lacosamide) – UCB
Keppra(Levetiracetam) – UCB
Briviact(Brivaracetam) – UCB
Lamictal(Lamotrigine) – GlaxoSmithKline
Neurontin (Gabapentin) – Pfizer
Depakine (Sodium Valproate) – Sanofi
Sabril (Vigabatrin) – Lundbeck
Onfi(Clobazam) – Lundbeck
Epilepsy Drugs Market – Major Deal Types:
Epilepsy Drugs Market – Collaboration Deals
Epilepsy Drugs Market – Licensing Agreement
Epilepsy Drugs Market – Partnerships Deals
List of Tables:
Table 3 1: Worldwide – Epilepsy Drugs Market Share(Percent),2013 – 2016
Table 3 2: Worldwide – Forecast for Epilepsy Drugs Market Share(Percent),2017 – 2021
Table 4 1: Epilepsy Branded Drugs Price List(US$),2017
Table 6 1: Collaboration Deals in Epilepsy Drug Market, 2008 – 2017
Table 6 2: Licensing Agreement in Epilepsy Drug Market, 2008 – 2016
Table 6 3: Partnerships Deals in Epilepsy Drug Market, 2008 – 2016
List of Figures:
Figure 2–1: Worldwide – Epilepsy Drugs Market (Million US$),2013 – 2016
Figure 2–2: Worldwide – Forecast for Epilepsy Drugs Market (Million US$),2017 – 2021
Figure 5–1: Worldwide – Vimpat Drug Sales (Million US$), 2013 – 2016
Figure 5–2: Worldwide – Forecast for Vimpat Drug Sales (Million US$), 2017 – 2021
Figure 5–3: Worldwide – Keppra Drug Sales (Million US$), 2013 – 2016
Other Related Reports Pharmaceuticals:
http://www.marketreportsonline.com/cat/pharmaceuticals-market-research.html
About Us:
MarketReportsOnline comprises of an online library of 2,50,000 reports and in-depth market research studies of over 5000+ micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.
Contact Us:
Ritesh Tiwari
2nd Floor, Metropole,
Next to Inox Theatre,
Bund Garden Road,
Pune - 411001.
Maharashtra, India.
Tel: + 1 888 391 5441
E-mail:
[email protected]